Search Results for

Showing 1 - 5 of 5 results
  1. Spotlight on members: Spark

    Spotlight on members From hospital funding to FDA approval Spark Therapeutics develops gene therapy for inherited retinal blindness After over two decades of research and development in gene therapy, Katherine A. High, MD, co-founder, president and chief scientific officer of Spark Therapeutics, is breathing a big sigh of relief this fall. On Oct. 12, the Food and Drug Administration unanimously voted to approve voretigene neparvovec, Spark Therapeutics' gene therapy treatment for inherited b

  2. Journals and Publications landing

    Journals and Publications ARVO Journals           Publications Grant The ARVO Publications Grant is available to authors who need funding assistance to publish in one of our three journals: Investigative Ophthalmology & Visual Science  (IOVS); Journal of Vision (JOV); and Translational Vision Science & Technology (TVST). This grant is supported by the ARVO Foundation and aligns with ARVO’s goal to capture the full spectrum of vision science in our family of journals. Several indivi

  3. MIN

    Members in the News Champalimaud MiN

  4. MIN

    Members in the News Champalimaud MiN

  5. Members in the News

    Members in the News ARVO members making headlines around the world Champalimaud Lisa Keay Member Obituaries